Investors are considering alternative strategies for purchasing shares of Treace Medical Concepts (TMCI), Insulet Corp (PODD), Oscar Health (OSCR), and Cytokinetics (CYTK) amid market caution. TMCI offers a March 2025 put at a $5 strike with a 21.2% annualized return potential, while PODD's December put at a $165 strike offers a 16.5% annualized return. Oscar Health reported a notable $56 million net income in Q2, marking its second quarterly profit, and is exploring put options with a January 2025 strike at $13, offering a 21.4% annualized return. Cytokinetics, with a current share price of $54.22, presents a January 2025 put at a $45 strike with a 28.7% annualized return. Each option strategy involves risks, primarily the potential for shares to fall below strike prices before contracts are exercised. Investors should weigh these options against the historical volatility and market conditions.